Melanotan II vs Oxytocin
Well Studied vs FDA Approved
monitor Mechanism-based · 51% Both Melanotan II and Oxytocin can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar).
Molecular Data
Melanotan II Oxytocin
Weight — 1,007.19 Da
Half-life ~2 hours 3-6 minutes
Chain — 9 amino acids
Type Synthetic alpha-MSH analog Cyclic nonapeptide
Key Benefits
Melanotan II
01 Rapid tanning without UV exposure
02 Enhanced sexual function and libido
03 Appetite suppression
04 Improved mood via melanocortin activation
05 Photoprotection through increased melanin
Oxytocin
01 FDA-approved for labor induction with precise dosing via IV
02 Immediate onset in obstetric settings
03 Established safety profile in clinical use
04 Researched for anxiety, PTSD, autism, sexual dysfunction
Dosing Protocols
Melanotan II
Loading: Start 0.25mg daily, increase to 0.5-1mg; Maintenance: 0.5-1mg 2-3x weekly / Loading phase: Daily for first week, then tanning maintenance 2-3x weekly or as needed for sexual enhancement
Initial loading phase 0.25mg 1x daily
Tanning maintenance 0.5-1mg 2-3x weekly
Sexual enhancement 0.5-1mg As needed
Minimal side effects 0.1-0.25mg Every other day
Photoprotection 0.5mg 2x weekly
Oxytocin
Intranasal: 20-24 IU; Injectable: 10-40 IU; Sublingual: 50-100 IU / As needed for social/sexual support, or 1-2x daily for anxiety/PTSD protocols; max 1 dose per 24hr for sexual function
Labor Induction 0.5-2 mU/min initial, titrate to 1-2 mU/min every 30-60 min Continuous IV infusion
Postpartum Hemorrhage Prevention 10 units IM or 10-40 units in IV solution Single dose after placental delivery
Side Effects
Melanotan II
Nausea (pre-treatment with antiemetics recommended)
Facial flushing
Temporary blood pressure elevation
Fatigue
Spontaneous erections
Oxytocin
Mild headache
Nasal irritation (intranasal)
Nausea or vomiting
Transient blood pressure changes
Contraindications
History of melanoma or dysplastic nevi
Pregnancy or breastfeeding
Cardiovascular conditions
Uncontrolled hypertension
Certain obstetric conditions (see prescribing info)
Pregnancy (without medical supervision)
Active sinus infection (intranasal)
Severe hyponatremia
Research Evidence
Melanotan II Oxytocin
Status Well Studied FDA Approved
References 4 studies 3 studies
Latest 2024 —
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.